Alliance Healthcare GroupSGX:MIJ 54 ROE % is 12.16% as of Dec. 2025, which is 8% above its 10-year median of 11.29. GuruFocus rates SGX:MIJ with a GF Score™ of 54/100 and a GF Value™ of S$0.18 (Modestly Undervalued). The stock has 10 warning signs investors should review. Among 624 Healthcare Providers & Services companies, Alliance Healthcare Group ranks better than 66.99% on this metric.
The historical rank and industry rank for Alliance Healthcare Group's ROE % or its related term are showing as below:
SGX:MIJ'
s ROE % Range Over the Past 10 Years
Min: 2.71 Med: 11.29 Max: 58.9
Current: 11.29
During the past 10 years, Alliance Healthcare Group's highest ROE % was 58.90%. The lowest was 2.71%. And the median was 11.29%.
SGX:MIJ's ROE % is ranked better than 66.99% of 624
companies
in the Healthcare Providers & Services industry
Industry Median: 5.85
vs SGX:MIJ: 11.29
Alliance Healthcare Group (SGX:MIJ) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Alliance Healthcare Group's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alliance Healthcare Group ROE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Alliance Healthcare Group's ROE % distribution charts can be found below:
* The bar in red indicates where Alliance Healthcare Group's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
ROE % is displayed in the 30-year financial page.
Alliance Healthcare Group (SGX:MIJ) has a ROE % of 12.16% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Alliance Healthcare Group and its competitors. This is near median its historical median of 11.29. Over the past decade, Alliance Healthcare Group's ROE % has ranged from 2.71 to 58.90. According to the industry distribution chart, Alliance Healthcare Group ranks #206 out of 624 companies in the Healthcare Providers & Services industry, placing it in the top 33%.
Is Alliance Healthcare Group's ROE % too high?
Alliance Healthcare Group's current ROE % of 12.16% is near median its 10-year median of 11.29. Over the past 10 years, this metric has ranged from a low of 2.71 to a high of 58.90. The Healthcare Providers & Services industry median ROE % is 5.85. Alliance Healthcare Group's value of 12.16% is 107.9% above this industry median. Based on the distribution chart, Alliance Healthcare Group ranks #206 out of 624 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Alliance Healthcare Group has a GF Score™ of 54/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alliance Healthcare Group's ROE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Alliance Healthcare Group ranks #206 out of 624 companies for ROE %. This puts Alliance Healthcare Group in the upper half of its industry. The industry median ROE % is 5.85. Alliance Healthcare Group's value of 12.16% is 107.9% above this benchmark. Historically, Alliance Healthcare Group's own ROE % has ranged from 2.71 to 58.90 over the past decade. While the company's 10-year median is 11.29 vs. the industry median of 5.85, Alliance Healthcare Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.85, based on 624 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alliance Healthcare Group's current ROE % of 12.16% is 107.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Alliance Healthcare Group and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alliance Healthcare Group's current ROE % is 12.16%, which is near median its own 10-year median of 11.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alliance Healthcare Group stock overvalued right now?
Based on GuruFocus' analysis, Alliance Healthcare Group (SGX:MIJ) is currently considered Modestly Undervalued. The stock's GF Value™ is S$0.18, compared to a current price of S$0.16 — trading 12.2% below its estimated fair value. The current ROE % is 12.16%, which is near median its 10-year median of 11.29 and 107.9% above the Healthcare Providers & Services industry median of 5.85. Alliance Healthcare Group's overall GF Score™ is 54/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Alliance Healthcare Group (SGX:MIJ), the current ROE % is 12.16% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alliance Healthcare Group (SGX:MIJ) Overvalued in 2026?
Based on GuruFocus' analysis, Alliance Healthcare Group stock appears to be undervalued.
The current stock price of S$0.16 is trading 12.2% below its estimated GF Value™ of S$0.18.
GuruFocus considers Alliance Healthcare Group to be Modestly Undervalued.
Key valuation signals for SGX:MIJ:
ROE %: 12.16% (near median its 10-year median of 11.29)
GF Value™: S$0.18 vs. price of S$0.16 (12.2% below fair value)
Industry Position: 107.9% above the Healthcare Providers & Services median (#206 of 624)
No single metric tells the full story. See the SGX:MIJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alliance Healthcare Group Ltd is engaged in investment holding and health-related services. Its segments include GP clinic services providing primary healthcare by general practitioners, specialist care services by medical specialists, and managed healthcare solutions delivering healthcare to employees of corporations. The pharmaceutical services segment wholesales medicines, health supplements, and medical devices. The mobile and digital health services segment offers medical care through mobile and home services. The others segment includes investment holding and administrative services. The company generates the majority of its revenue from pharmaceutical services. The company generates the majority of its revenue from Singapore and has a presence in Europe and the Asia Pacific region.
54GF Score
Get the complete analysis for SGX:MIJ
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:MIJ has been successfully added to your 
